Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Hepatol. 2017 Feb 2;66(6):1173–1181. doi: 10.1016/j.jhep.2017.01.020

Fig. 2. Percentage of patients who failed hepatitis C therapy at the end of treatment and at 12 weeks post-treatment.

Fig. 2

EOT, end of treatment; HCC, hepatocellular carcinoma. *t test used for statistical analysis.